A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2004
12/30/2004	US20040266841 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
12/30/2004	US20040266839 2'-Methyl-5-(1,3,4-oxadiazol-2-yl)1,1'-biphenyl-4-carboxaide derivatives and their use as p38 kinase inhibitors
12/30/2004	US20040266826 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
12/30/2004	US20040266823 Such as N-[1-(3-phenyl-3-benzoylamino]propyl)-4-piperidinyl]-N-ethylmethanesulfonylphenylacetamide; autoimmune and inflammatory diseases; rheumatoid arthritis; synthesis
12/30/2004	US20040266822 Secondary amines; tissue specificity; reduced side effects; cardiovascular diseases, diabetes, bronchial and urinary smooth muscle spasms, ischemia, anoxic nerve injury
12/30/2004	US20040266816 Potent and long lasting antimuscarinic agents; respiratory, urological or gastrointestinal disorders
12/30/2004	US20040266805 Inflammation modulatory compound
12/30/2004	US20040266782 Cyclic amine derivatives-CCR-3 receptor antagonists
12/30/2004	US20040266780 Inhibitors of human phosphatidyl-inositol 3-kinase delta
12/30/2004	US20040266775 for human, veterinary, or phytoprotective use, e.g., inhibiting the cellular sodium-proton antiporter activity, for the treatment of cardiovascular diseases, metabolic diseases, cancerous diseases or fibrotic diseases
12/30/2004	US20040266764 Hydroxamic acid derivatives
12/30/2004	US20040266750 Beta-lactamyl vasopressin v1aantagonists
12/30/2004	US20040266733 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor Type-1 (PAI-1)
12/30/2004	US20040266710 Immunotherapy; induce immunology response
12/30/2004	US20040266709 Immunotherapy; induction immunology response
12/30/2004	US20040266694 Angiogenesis inhibitor induced by vascular endothelial growth factor
12/30/2004	US20040266687 Antiproliferative agents; antiinflammatory agents; angiogenesis inhibitors; anticancer agents
12/30/2004	US20040265968 Tissue plasminogen activator-like protease
12/30/2004	US20040265885 Peptide nucleic acid (PNA) derivatives which carry one or more phosphoryl radicals at the N terminus of the PNA backbone; can be purified using efficient methods such as chromatography or electrophoresis; use as pharmaceuticals and diagnostic agents
12/30/2004	US20040265807 Enzymes
12/30/2004	US20040265382 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery
12/30/2004	US20040265358 Modified methionine rich food products and process for their manufacture
12/30/2004	US20040265316 An antibody which specifically binds to a Fhit (fragile histidine triad) protein or derivative
12/30/2004	US20040265314 Soluble CLCA-1 and antagonists to CLCA-1
12/30/2004	US20040265241 Methods for the inhalation administration of antibiotics
12/30/2004	US20040261190 Hydrazono-malonitriles
12/29/2004	WO2004113372A1 MODIFIED BORDETELLA ADENYLATE CYCLASE COMPRISING OR LACKING CD11b/CD18 INTERACTION DOMAIN AND USES THEREOF
12/29/2004	WO2004113303A1 INDAZOLE/PYRZOLO[4,3-c]PYRIDIN DERIVATIVES AS JNK INHIBITORS, COMPOSITIONS AND METHODS RELATED THERETO AS WELL AS INTERMEDIATE THEREOF
12/29/2004	WO2004113302A1 N-substituted 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators
12/29/2004	WO2004113300A1 Novel tricyclic heterocycle compound
12/29/2004	WO2004112795A1 Ltb4 compositions for treating tract infections
12/29/2004	WO2004112791A1 Therapeutic and/or preventive agent for lung disease
12/29/2004	WO2004112771A1 Pharmaceutical compositions including an antihistamine and a stimulant and use thereof
12/29/2004	WO2004112770A1 Adhesive patch containing tulobuterol
12/29/2004	WO2004112708A2 Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals
12/29/2004	WO2003103671A8 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
12/29/2004	WO2003035790A9 Improved method for generating an aerosol
12/29/2004	WO2003015797A8 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine
12/29/2004	WO2002043648A3 Compounds active at the glucocorticoid receptor ii
12/29/2004	WO2000061774A3 Bone morphogenic proteins
12/29/2004	EP1491532A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetyloholine receptors
12/29/2004	EP1491209A1 Diagnostics and remedies for interstitial pneumonia
12/29/2004	EP1491207A1 Novel screening method
12/29/2004	EP1491204A1 Process for producing fat composition containing hydrophobic components of glycyrrhiza
12/29/2004	EP1491203A1 Compositions for treating and/or preventing pollenosis
12/29/2004	EP1490696A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
12/29/2004	EP1490406A1 Costimulatory molecule and its use
12/29/2004	EP1490405A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
12/29/2004	EP1490367A1 Imidazopyridine derivatives as kinase inhibitors
12/29/2004	EP1490366A1 Novel alkoxypyridine-derivatives
12/29/2004	EP1490364A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
12/29/2004	EP1490357A1 Stable hydrate of a muscarinic receptor antagonist
12/29/2004	EP1490352A1 Synthesis of piperidine and piperazine compounds as ccr5 antagonists
12/29/2004	EP1490343A1 New aryl imidazoles and related compounds as c5a receptor modulators
12/29/2004	EP1490341A1 Novel adamantane derivatives
12/29/2004	EP1490340A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
12/29/2004	EP1490339A1 Novel chalcone derivatives and uses thereof
12/29/2004	EP1490317A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/29/2004	EP1490315A1 Controlling chemical reactions by spectral chemistry and spectral conditioning
12/29/2004	EP1490119A1 Tissue treatment
12/29/2004	EP1490110A2 Anti-alpha v beta 6 antibodies
12/29/2004	EP1490103A2 Process for manufacturing pharmaceutical composition comprises of mycobacterium w in the treatment of asthama(obstructive lung disease)
12/29/2004	EP1490072A1 Novel therapeutical use of agonist ligands specific to g2a receptor
12/29/2004	EP1490071A2 Theraputic methods and uses of sapogenins and their derivatives
12/29/2004	EP1490070A2 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
12/29/2004	EP1490065A1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors
12/29/2004	EP1490064A1 Substituted pyridinones as modulators of p38 map kinase
12/29/2004	EP1490054A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer
12/29/2004	EP1490048A1 Pharmaceutical composition for preventing or treating respiratory disease
12/29/2004	EP1490044A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
12/29/2004	EP1490043A2 Spirocyclic amides as cannabinoid receptor modulators
12/29/2004	EP1490042A2 Use of ltb4 antagonists in veterinary medicine
12/29/2004	EP1489924A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
12/29/2004	EP1489915A1 Treatment and prevention of inflammatory disorders
12/29/2004	EP1379220B1 Inhalation capsules
12/29/2004	EP1257539B1 Amino pyrazole derivatives useful for the treatment of obesity and other disorders
12/29/2004	EP1244657B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
12/29/2004	EP1210069B1 Large porous particles obtainable by spray-drying and suitable for pulmonary administration
12/29/2004	EP1171419B1 Biphenyl derivatives as antagonists of the neurokinine-1 receptor
12/29/2004	EP1148059B1 Thiazolopyrimidine compounds, process for the preparation of the same and uses thereof
12/29/2004	EP1135123B1 Use of isatin derivatives as ion channel activating agents
12/29/2004	EP1119551B1 Naphthalenecarboxamides as tachykinin receptor antagonists
12/29/2004	EP1117643B1 New crystal modification n of torasemide
12/29/2004	EP0910390B1 Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
12/29/2004	CN1558907A Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
12/29/2004	CN1558775A Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
12/29/2004	CN1558767A A pharmaceutical composition made from Chinese traditional medicine for treating snuffle, headache and preparation method thereof
12/29/2004	CN1558765A Enantiomerically pure opioid diarylmethylpiperzine and methods of using same
12/29/2004	CN1557826A Method for extracting astragaloside and polysaccharide from traditional Chinese medicine astragalus and its capsule preparation
12/29/2004	CN1557494A Preparation of microorganism resisting biological active component and its application
12/29/2004	CN1557489A Preparation of oral administered immune globulin from whey
12/29/2004	CN1557485A Application of gene recombined human lysozyme in eliminating pathogenic microorganism infection
12/29/2004	CN1557484A Chaenomeles fruit element contained lozenge and its preparation
12/29/2004	CN1557458A Medicinal liquor for treating cough, acute and chronic bronchitis and asthma
12/29/2004	CN1557450A Chinese medicinal preparation for treating infant tracheitis
12/29/2004	CN1557435A Inflammation-eliminating and cough-relieving medicinal capsule and its preparing process
12/29/2004	CN1557432A Preparing process of medicinal composition for treating acute and chronic bronchitis
12/29/2004	CN1557431A Cough resisting prescription and its preparing process
12/29/2004	CN1557423A Chinese traditional medicine for treating allergic rhinitis
12/29/2004	CN1557410A Chinese medicine composition prescription for treating pulmonary heart disease and its preparation process

1 ... 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 ... 878